newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Net product revenue from Avenova®-branded eyecare products grew 7% year-over-year, reflecting an increased contribution from the physician dispensed channel Sales and marketing expenses declined 7% versus the